Glaxosmithkline | GSK - Eps Gewinn Pro Aktie

Aktienkurs
58.22
Täglich Wechseln
-0.90 -1.52%
Monatlich
%
Jährlich
68.07%
Q2 Prognose
57.14

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2025Q1 Mar/2026 1.17 0.52 Apr/29




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Aurora Cannabis CAD -0.64 0.36 2025-12
Bausch Health Companies USD 1.08 0.08 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Canopy Growth CAD -0.05 0.03 2025-12
Corcept Therapeutics USD 0.2 0.04 2025-12
Drreddys Laboratories INR 0.16 0.04 2025-12
Eli Lilly USD 7.54 0.52 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
J&J USD 2.46 0.34 2025-12
Merck USD 2.04 0.54 2025-12
Novartis USD 1.54 0.5 2025-12
Pacira USD 0.06 0.64 2025-12
Perrigo USD 0.77 0.03 2025-12
Pfizer USD 0.66 0.21 2025-12
Phibro Animal Health USD 0.78 0.1 2025-12
Prestige Brands USD 1.14 0.07 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12
Supernus Pharmaceuticals USD -0.07 0.73 2025-12
Takeda JPY 65.74 73.57 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
Zoetis USD 1.48 0.22 2025-12